Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report)’s stock price was down 3.8% during mid-day trading on Wednesday . The company traded as low as $0.45 and last traded at $0.45. Approximately 214 shares traded hands during mid-day trading, a decline of 88% from the average daily volume of 1,835 shares. The stock had previously closed at $0.47.
Zelira Therapeutics Stock Performance
The business’s 50 day moving average is $0.49 and its 200 day moving average is $0.43.
About Zelira Therapeutics
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Further Reading
- Five stocks we like better than Zelira Therapeutics
- What is the S&P 500 and How It is Distinct from Other Indexes
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Conference Calls and Individual Investors
- Williams-Sonoma Stock: Buy It and Never Let It Go
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
